ABCA1 and atherosclerosis: Moreover, the ability of TFEB to mitigate the progression of atherosclerosis is partly due to its induction of the cholesterol efflux regulatory protein, ATP‐binding cassette transporter (ABCA1), and concomitant downregulation of the class B scavenger receptor, CD36 (Li et al, 2016a).